The Dark Side of Onglyza and Heart Failure
Those afflicted with Type 2 diabetes need medication to control their high blood sugar and end up turning to the dominate prescriptions on the market: Onglyza and Kombiglyze XR. Released in 2009, Onglyza quickly became a popular choice of medication to control blood sugar amongst Type 2 diabetics since it didn’t cause excess weight gain
Read More
The Michael Brady Lynch Firm Files 2nd Invokana Ketoacidosis Lawsuit
December 15, 2015 For Immediate Release: The Michael Brady Lynch Firm announces the filing of the nation’s second Invokana ketoacidosis lawsuit. About Invokana Ketoacidosis Lawsuit The case, Luana Jean Collie v. JANSSEN RESEARCH & DEVELOPMENT, LLC; JANSSEN PHARMACEUTICALS, INC.; JOHNSON & JOHNSON CO.; and MITSUBISHI TANABE PHARMA CORP., was filed in the United States District
Read More
Association Between Viagra Usage and Risk of Melanoma
There is a growing epidemic in America. In 1998, the FDA approved Viagra as a medication to increase blood flow to help treat erectile dysfunction. The global revenues for this ED drug have reached a staggering $1.6 billion. However, big pharmaceutical companies keep getting richer while unsuspecting Viagra users are unaware they may be more
Read MoreFDA Requires New Ketoacidosis Warning for Invokana
This is Michael Brady Lynch, lead trial attorney for The Michel Brady Lynch Firm. Well, it is about time the FDA acted on the problem of ketoacidosis and the drug Invokana. December 4, 2015 Invokana and SGLT2 Inhibitors: Drug Safety Communication – Labels to Include Warnings About Too Much Acid in the Blood and Serious
Read MoreSupport An End to Big Pharma Direct to Consumer Advertising
AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices. This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In what is hopefully a precedent-setting stance on direct-to-consumer drug advertising to American consumers, the American Medical Association has taken a commendable stance to end this
Read MorePradaxa: A Case Study In A Broken FDA Approval System
The FDA Failed Pradaxa Users. This is attorney Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The deeper one delves into the tragic history of the prescription blood thinner Pradaxa, more troubling facts emerge concerning our drug approval process. And both the FDA and Pradaxa manufacturer Boehringer Ingelheim is to blame.
Read More